Search Browse Earnings

Boundless Bio, Inc. — SlamSEC

Boundless Bio, Inc.

Nasdaq:BOLD

Pharmaceutical Preparations·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$72.2M

FY 2025

Net Income

-$65.4M

FY 2025

EPS (Diluted)

-$3.85

FY 2025

Stock Price

$1.12

-0.2%

2026-03-13

52W Range

$0.96 – $1.79

P/E Ratio

-0.3x

Market Cap

$25.1M

Cash

$26.6M

FY 2025

Total Debt

—

Net Cash

$26.6M

Enterprise Value

-$1.5M

Debt / EBITDA

0.4x

FY 2025

EV / EBITDA

0.0x

Employees

—